AzTrials
AzTrials

Neurodevelopmental DisordersNCT02118649

Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game

A study testing Game in people with Neurodevelopmental Disorders, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Participants will play a computer game that is controlled by their gaze patterns and designed to direct attention their attention to specific on-screen targets. Visual attention to targets will be rewarded. Both visual behavior and brain response will be recorded during game play. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Neurodevelopmental Disorders
What is being tested?
Game
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
1 Apr 2014to 18 Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Able to participate in an eye-tracking experiment
  • Able to participate in an EEG experiment

Who cannot join

  • Sensory or physical impairment that would preclude completion of protocol
  • Participants taking prescription medications that may affect cognitive processes
  • Participants reporting significant head trauma or history of seizures

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale Child Study Center

    New Haven, Connecticut, 06520

Other trials in United States

About this study

Participants will play a computer game that is controlled by their gaze patterns and designed to direct attention their attention to specific on-screen targets. Visual attention to targets will be rewarded. Both visual behavior and brain response will be recorded during game play.

It is hypothesized that that, over the course of the game, relative to baseline, participants will show (a) increased looking to targets, (b) decreased response time to targets, and (c) enhanced, more efficient neural response to visual cues. It is hypothesized that clinical variability will associate with visual attention and brain response.

Being tested
Game
Medical subject headings
Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GameBehavioural

Study groups in NCT02118649
Study groupRoleWhat they receive
GameExperimentalParticipants will play a video game directing their gaze to on-screen targets.
Receives: Behavioral: Game

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EEG brain response to targets

    Measured: Measures will be recorded for the duration of their visit, an expected average of 3 hours.

Secondary outcomes (6)
  1. Visual attention to targets as measured by eye-tracking

    Measured: Measures will be recorded for the duration of their visit, an expected average of 3 hours.

  2. Social Responsiveness Scale, Second Edition

    Measured: Measures will be collected during visit, an expected average of 3 hours.

  3. Autism Diagnostic Observation Schedule

    Measured: Measures will be collected during visit, an expected average of 3 hours.

  4. Differential Abilities Scale

    Measured: Measures will be collected during visit, an expected average of 3 hours.

  5. Vineland Adaptive Behavior Scales, Second Edition

    Measured: Measures will be collected during visit, an expected average of 3 hours.

  6. Social Anxiety Scale for Children, Revised

    Measured: Measures will be collected during visit, an expected average of 3 hours.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2014 (estimated)
  2. Study start1 Apr 2014
  3. Primary completion18 Jul 2017
  4. Study completion18 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02118649
Sponsor's protocol ID
14-10788
Status last verified
Aug 2026
First submitted
5 Apr 2014
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Hutt C, Ounsted C. The biological significance of gaze aversion with particular reference to the syndrome of infantile autism. Behav Sci. 1966 Sep;11(5):346-56. doi: 10.1002/bs.3830110504. No abstract available.

    PubMed 5970485
  • Senju A, Tojo Y, Yaguchi K, Hasegawa T. Deviant gaze processing in children with autism: an ERP study. Neuropsychologia. 2005;43(9):1297-306. doi: 10.1016/j.neuropsychologia.2004.12.002. Epub 2005 Jan 24.

    PubMed 15949514
  • Senju A, Yaguchi K, Tojo Y, Hasegawa T. Eye contact does not facilitate detection in children with autism. Cognition. 2003 Aug;89(1):B43-51. doi: 10.1016/s0010-0277(03)00081-7.

    PubMed 12893128
  • Tanaka JW, Wolf JM, Klaiman C, Koenig K, Cockburn J, Herlihy L, Brown C, Stahl S, Kaiser MD, Schultz RT. Using computerized games to teach face recognition skills to children with autism spectrum disorder: the Let's Face It! program. J Child Psychol Psychiatry. 2010 Aug;51(8):944-52. doi: 10.1111/j.1469-7610.2010.02258.x.

    PubMed 20646129
  • Tanaka JW, Wolf JM, Klaiman C, Koenig K, Cockburn J, Herlihy L, Brown C, Stahl SS, South M, McPartland JC, Kaiser MD, Schultz RT. The perception and identification of facial emotions in individuals with autism spectrum disorders using the Let's Face It! Emotion Skills Battery. J Child Psychol Psychiatry. 2012 Dec;53(12):1259-67. doi: 10.1111/j.1469-7610.2012.02571.x. Epub 2012 Jul 11.

    PubMed 22780332
  • Charlop-Christy MH, Le L, Freeman KA. A comparison of video modeling with in vivo modeling for teaching children with autism. J Autism Dev Disord. 2000 Dec;30(6):537-52. doi: 10.1023/a:1005635326276.

    PubMed 11261466
  • Gena A, Couloura S, Kymissis E. Modifying the affective behavior of preschoolers with autism using in-vivo or video modeling and reinforcement contingencies. J Autism Dev Disord. 2005 Oct;35(5):545-56. doi: 10.1007/s10803-005-0014-9.

    PubMed 16163569
  • Wilson KP. Teaching social-communication skills to preschoolers with autism: efficacy of video versus in vivo modeling in the classroom. J Autism Dev Disord. 2013 Aug;43(8):1819-31. doi: 10.1007/s10803-012-1731-5.

    PubMed 23224593
  • Klin A, Jones W, Schultz R, Volkmar F, Cohen D. Defining and quantifying the social phenotype in autism. Am J Psychiatry. 2002 Jun;159(6):895-908. doi: 10.1176/appi.ajp.159.6.895.

    PubMed 12042174
  • Landa RJ, Holman KC, O'Neill AH, Stuart EA. Intervention targeting development of socially synchronous engagement in toddlers with autism spectrum disorder: a randomized controlled trial. J Child Psychol Psychiatry. 2011 Jan;52(1):13-21. doi: 10.1111/j.1469-7610.2010.02288.x. Epub 2010 Dec 3.

    PubMed 21126245
  • Constantino, J. N., & Gruber, C. P. (2012). The Social Responsiveness Scale, Second Edition. Los Angeles, CA: Western Psychological Services.

  • Lord, C., Rutter, M., DiLavore, P. C., & Risi, S. (1999). Autism Diagnostic Observation Schedule - WPS (ADOS-WPS), Los Angeles, CA: Western Psychological Services.

  • Elliott C. Differential Ability Scales: Second Edition (DAS-II). San Antonio, TX: Psychological Corporation. 2007.

  • Sparrow, S. S., Balla, D., Cicchetti, D. (1984). Vineland Adaptive Behavior Scales. Circle Pines, MN, American Guidance Service.

  • La Greca AM, Lopez N. Social anxiety among adolescents: linkages with peer relations and friendships. J Abnorm Child Psychol. 1998 Apr;26(2):83-94. doi: 10.1023/a:1022684520514.

    PubMed 9634131

Questions about this trial

What is this clinical trial studying?

A study testing Game in people with Neurodevelopmental Disorders, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EEG brain response to targets (time frame: Measures will be recorded for the duration of their visit, an expected average of 3 hours.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02118649, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in